The FDA classified the recall as a Class I, the most serious type, according to a Feb. 23 news release.
A total of 35 complaints have been received since December 2021. Of the 35 complaints, there have been 14 reported injuries, and nine complaints involved use of a stent to manage the separated tip. No deaths have been reported at this time, according to the FDA.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
